US Patent Family Members and Approved Drugs for Japan Patent: 5047996
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: JP5047996
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| ⤷ Start Trial | 2019-03-12 | eculizumab | Alexion Pharmaceuticals, Inc. | SOLIRIS |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
